Genetic and forensic implications in epilepsy and cardiac arrhythmias: a case series

Epilepsy affects approximately 3 % of the world’s population, and sudden death is a significant cause of death in this population. Sudden unexpected death in epilepsy (SUDEP) accounts for up to 17 % of all these cases, which increases the rate of sudden death by 24-fold as compared to the general po...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of legal medicine Vol. 129; no. 3; pp. 495 - 504
Main Authors Partemi, Sara, Vidal, Monica Coll, Striano, Pasquale, Campuzano, Oscar, Allegue, Catarina, Pezzella, Marianna, Elia, Maurizio, Parisi, Pasquale, Belcastro, Vincenzo, Casellato, Susanna, Giordano, Lucio, Mastrangelo, Massimo, Pietrafusa, Nicola, Striano, Salvatore, Zara, Federico, Bianchi, Amedeo, Buti, Daniela, La Neve, Angela, Tassinari, Carlo Alberto, Oliva, Antonio, Brugada, Ramon
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.05.2015
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Epilepsy affects approximately 3 % of the world’s population, and sudden death is a significant cause of death in this population. Sudden unexpected death in epilepsy (SUDEP) accounts for up to 17 % of all these cases, which increases the rate of sudden death by 24-fold as compared to the general population. The underlying mechanisms are still not elucidated, but recent studies suggest the possibility that a common genetic channelopathy might contribute to both epilepsy and cardiac disease to increase the incidence of death via a lethal cardiac arrhythmia. We performed genetic testing in a large cohort of individuals with epilepsy and cardiac conduction disorders in order to identify genetic mutations that could play a role in the mechanism of sudden death. Putative pathogenic disease-causing mutations in genes encoding cardiac ion channel were detected in 24 % of unrelated individuals with epilepsy. Segregation analysis through genetic screening of the available family members and functional studies are crucial tasks to understand and to prove the possible pathogenicity of the variant, but in our cohort, only two families were available. Despite further research should be performed to clarify the mechanism of coexistence of both clinical conditions, genetic analysis, applied also in post-mortem setting, could be very useful to identify genetic factors that predispose epileptic patients to sudden death, helping to prevent sudden death in patients with epilepsy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0937-9827
1437-1596
DOI:10.1007/s00414-014-1063-4